Delivery Order SPE2DB20D1100-SPE2DB25FD6A5
- Not listed
- This is a $1,518.84 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% cream, 45 grams, with a performance period ending on July 16, 2025. The contract is not a set-aside and was awarded on July 15, 2025. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,225.07 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ivermectin 1% cream (45 gm). This delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- The Defense Logistics Agency Troop Support Medical awarded a $855.77 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 1% ivermectin cream in 45-gram tubes. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 20-21, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical supply...
- This federal contract award, valued at $1,020.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of 4568239606 - IVERMECTIN 1% CREAM 45GM, with a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.56 Firm Fixed Price Delivery Order is for the supply of 4566602576 Ivermectin 1% Cream, 45GM. The award has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,552.84 firm fixed-price contract is for the delivery of Ivermectin 1% cream, a medication used to treat certain skin conditions. The contract is not designated as a set-aside and is therefore open to full and open competition. It has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor and...
- The Defense Logistics Agency awarded a $57,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 3 mg ivermectin tablets. As the prime contractor, Amerisourcebergen will deliver 20 count bottles of the pharmaceutical product to a facility in Conshohocken, Pennsylvania under a one day period of performance from September 13-14, 2023. The order was placed against an existing DLA contract vehicle in support of the agency's medical supply procurement programs. No...
- This federal contract award is for the delivery of IVERMECTIN 1% CREAM 45GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,542.93 and a ceiling value of $1,542.93. The ultimate completion date is December 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $11,561.05 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in 30-gram containers. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6A5Delivery Order
The Defense Logistics Agency awarded a $1,340.43 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ivermectin 1% Cream in 45-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement requirements. The order is set for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The company's contract portfolio with DLA demonstrates extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/23/25 |